Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
A standardized procedure for the management of investigational agents is essential to enhance patient safety while ensuring adherence to regulatory requirements. This process includes implementing safeguards to avoid the selection of expired or quarantined agents during dispensing, thereby reducing the chance of providing medication to patients not participating in a study. It is crucial to meticulously capture all dispensing details and document them in the Drug Accountability Record Form (DARF). Additionally, measures should be taken to prevent the distribution of drugs that may expire within the treatment period by thoroughly assessing the dispense date, available supply, and expiration date. Tracking details such as drug thaw time, reconstitution time, and temperature readings at the time of reconstitution is also vital. The centralized electronic management of investigational agents enhances clarity, minimizes paperwork and handwriting errors, and simplifies inventory management, allowing pharmacists to dedicate more time to critical tasks and patient care. Furthermore, while DARFs can be tailored using various filters, they still maintain a uniform appearance across all protocols, regardless of the sponsor involved, ensuring consistency and ease of use for all parties. This comprehensive approach to managing investigational agents ultimately contributes to a safer and more efficient clinical trial environment.
Description
Rhizome serves as an AI regulatory collaborator specifically designed for teams in the life sciences sector. While general AI assistants offer remarkable capabilities, there are distinct requirements for an AI tool that aids in making decisions regarding drugs or devices worth over $100 million.
Our agents are strictly limited to referencing facts derived from primary source documents, ensuring that nothing is validated based on agent memory; we assess their performance based on this criterion, and there have been no instances of inaccuracies reported in the past 18 months.
The databases that underpin regulatory decisions, including Drugs@FDA, guidance documents, clinicaltrials.gov, and various standards, often exist in formats that are not easily searchable by computers, with a significant amount being image-only PDFs. We have developed the ability to ingest and process all of this information, encompassing over 75 health authority databases across more than 12 markets as of August 2026, with this number continually growing. This equates to over 45 million documents that our agents can query comprehensively.
In contrast to a general assistant, which typically references 5 to 10 sources, Rhizome is capable of examining hundreds to thousands of documents, as the essential question is often, "Did we overlook a precedent?" This thorough approach ensures that our users are equipped with the most comprehensive and accurate information possible.
API Access
Has API
API Access
Has API
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
$17,000 per year
Free Trial
Free Version
Pricing Details
$0/month/user
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Ddots
Website
www.ddots.com/idea/
Vendor Details
Company Name
Rhizome AI
Founded
2023
Country
United States
Website
rhizomeai.com